Treating to target in type 2 diabetes

British Journal of Diabetes and Vascular Disease

Volumn 7, Issue 2, 2007, Pages 83-85

  Keigher, Carol ^a   Avalos, Gloria ^a   Dunne, Fidelma ^a  

^a UNIVERSITY HOSPITAL GALWAY   (Ireland)

Author keywords

Blood pressure; Glycaemic control; Lipids; Type 2 diabetes

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ORAL ANTIDIABETIC AGENT; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL EFFECTIVENESS; DIABETIC ANGIOPATHY; DIABETIC DIET; DIABETIC PATIENT; DIASTOLIC BLOOD PRESSURE; DRUG DOSE TITRATION; DYSLIPIDEMIA; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEALTH CARE POLICY; HEMOGLOBIN BLOOD LEVEL; HIGH RISK PATIENT; HUMAN; HYPERTENSION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRACTICE GUIDELINE; REFERENCE VALUE; SYSTOLIC BLOOD PRESSURE;

EID: 34249089544     PISSN: 14746514     EISSN: None     Source Type: Journal    
DOI: 10.1177/14746514070070020601     Document Type: Article

References (28)

1. Burant CF (ed.) Medical management of Type 2 Diabetes. 5th ed. Alexandria, VA, American Diabetes Association 2004.
2. American Diabetes Association. Economic costs of Diabetes in the US. In 2002. Diabetes Care 2003;26:917-32.
3. 1C levels. Cur Med Res Opin 2004; 20:1919.
4. Saydah SH, Fradkin J, Cowie CC. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA 2004;291:335-42.
5. UK Prospective Diabetes Study (UKPDS) Group: Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) Lancet 1998; 352:854-65.
6. Stratton IM, Adler AI, Neil HA et al. Association of glycaemia with-macrovascular and microvascular complications for type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000; 321:405-12.
7. Ethisham S, Barrett TG, Shaw NJ. Type 2 diabetes in UK children an emerging problem. Diabet Med 2000;17:867-71.
8. Rosenbloom AL, Joe JR, Young RS, Winter WE. Emerging epidemic of type 2 diabetes in youth. Diabetes Care 1999;22:345-54.
9. Herman WH, Teutsch SM, Geiss LS. Closing the Gap: The problem of Diabetes Mellitus in the United States. Diabetes Care 1985; 8:391-406.
10. Laakso M. Epidemiology of diabetic dyslipidaemia. Diabetes Review 1995;3408-22.
11. Arauz-Pacheco C, Parrott MA, Raskin P. The treatment of hypertension in adult patients with diabetes. Diabetes Care 2002;25:134-47.
12. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes. UKPDS 38. BMJ 1998;317:703-13.
13. Adler AI, Stratton IM, Neil HA et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36); prospective observational study. BMJ 2000;321:412-19.
14. Heart Outcomes Prevention Evaluation Study Investigators: Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE sub-study. Lancet 2000;355:253-9.
15. Lindholm LH, Ibsen H, Dahlof B et al. Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention for Endpoint reduction in hypertension study (LIFE). Lancet 2002; 359:1004-10.
16. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group: Major Outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs. diuretic: the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002;288:2981-97.
17. Heart Protection Study Collaborative Group MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo controlled trial. Lancet 2003; 361:2005-16.
18. Colhoun HM, Betteridge DJ, Durrington PN et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomized placebo-controlled trial. Lancet 2004; 364:685-96.
19. Standards of Medical Care. American Diabetes Association. Diabetes Care 2006;29:S4-S42.
20. Joint British Societies Guidance Version 2 on prevention of cardiovascular disease in Clinical Practice. Heart 2005; 91:1-52.
21. Dauolt B, Server PS, Poultor NR et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perivdopril as required versus atenolol adding beudro flumethiazid as required, in the Angl-Scandivarian Cardic Outcomes Trial -bloop pressure lowering arm (ASCOT BPLA) a multicentre randomised controlled trail. Lancet 2005;366:895-906.
22. Zauchetti A, Julius S, Kyeldsen S et al. Outcomes in subgroups of hypertensive patients treated with regimens based on valsartan and amlodipine: an anlysis of findings from the VALUE trail. J Hypertens 2006;24:2163-8.
23. Skyler JS, Weinstock RS, Raskin P. Use of inhaled insulin in a Basal/ Bolus Insulin Regimen in Type 1 Diabetic Subjects: A 6-month randomized comparative trial. Diabetes Care 2005;28:1630.
24. Norris SL, Engelgau MM, Narayan KM. Effectiveness of self-management training in type 2 diabetes; a systematic review of randomised controlled trials. Diabetes Care 2001;24:561-87.
25. Norris SL, Lau J, Smith SJ, Schmid CH, Engelgau MM. Self management education for adults with type 2 diabetes: a meta analysis of the effect on glycaemic control. Diabetes Care 2002;25:1159-71.
26. Gary TL, Genkinger JM, Guallar E, Peyrot M, Brancati FL. Meta-analysis of randomized educational and behavioural interventions in type 2 diabetes. Diabetes Educ 2003;29:488-501.
27. Skinner TC, Davies MJ, Heller S, Khunti K. The effects of a structured education programme on illness beliefs, quality of life and physical activity in individuals newly diagnosed with type 2 diabetes. Results from the DESMOND pilot group. Diabetic Medicine 2005.
28. Davies MJ, Heller S, Khunti K, Skinner TC. The DESMOND programme: from pilot phase to randomised control trial in a study of structured group education for people newly diagnosed with type 2 diabetes mellitus. Diabetic Medicine 2005;64:369-77.